Matthew Butler
Foot Surgery · Marlborough, MANPI 1154385078
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,937 of the $2,524 with a category attached, or 76.7%. Treace Medical Concepts, Inc. accounts for 91.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $2,166 and has fallen 98.0% since, to $43 in 2025.
Across 21 payments — averaging $120.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Smith+Nephew$46
- Paratek Pharmaceuticals, Inc.$36
- Orthofix Medical, Inc.$35
- Biopro, Inc.$31
- Averitas Pharma Inc.$31
- plus $31 from 2 others
What the payments were for
- Travel & lodging$1,93777%
- Food & beverage$58723%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 12 | $2,313 |
| Smith+Nephew | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Orthofix Medical, Inc. | 1 | $35 |
| Biopro, Inc. | 1 | $31 |
| Averitas Pharma Inc. | 1 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,060
How this compares
$2,524 in reported general payments places this provider in the 75th percentile of 41 foot surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 106 | $1,169 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $935 |
| Terbinafine Hcl | 95 | $838 |
| Betamethasone Dipropionate | 11 | $545 |
| Cephalexin | 24 | $136 |
| Gabapentin | 16 | $117 |
| Meloxicam | 50 | $99 |
| Tramadol Hcl | 30 | $79 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Marlborough
- Adam LandsmanBoston$385K
- Mark RoseNatick$9K
- Jamey AllenWoburn$8K
- Ewald MendeszoonWest Roxbury$6K
- Christopher LockeBoston$6K
- Jurgen FernandezLynn$4K
- Justin OgbonnaBoston$4K
- Neil FeldmanWorcester$4K
- Wei TsengBoston$3K
- Christine DalrympleNorth Andover$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.